Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity

Carcinoembryonic antigen (CEA) is a human glycoprotein involved in cellular adhesion and expressed during human fetal development. Although expression of CEA largely ceases prior to birth, several human epithelial cancers, including colorectal, gastric, squamous esophageal, and breast carcinomas hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Hensel, Jonathan A., Khattar, Vinayak, Ashton, Reading, Ponnazhagan, Selvarangan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329706/
https://www.ncbi.nlm.nih.gov/pubmed/30666318
http://dx.doi.org/10.1016/j.omto.2018.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329706/
https://www.ncbi.nlm.nih.gov/pubmed/30666318
http://dx.doi.org/10.1016/j.omto.2018.12.004

Ejemplares similares